Target intelligence / Profile preview

Inorganic phosphate ion (Pi) (Pi)

Target
Pi
Molecular classification
Inorganic ion, Electrolyte, Anion
01

Overview

Inorganic phosphate ions in saliva are essential electrolytes that play a pivotal role in maintaining oral homeostasis and dental integrity. They function as a primary component of the salivary buffering system, which neutralizes metabolic acids produced by dental plaque bacteria to prevent enamel demineralization (Humphrey & Williamson, 2001). These ions are also critical for the remineralization process, where they interact with calcium and fluoride to reform hydroxyapatite crystals in tooth enamel (Bardow et al., 2000). Beyond oral health, salivary phosphate levels serve as a significant non-invasive biomarker for systemic mineral imbalances, particularly in patients with Chronic Kidney Disease (CKD) who suffer from hyperphosphatemia (Savica et al., 2008). While the ions themselves are not traditional protein-based drug targets, they are the direct substrate for phosphate-binding agents like sevelamer and lanthanum carbonate, which are used to manage systemic phosphate levels (PubChem, 2024). Therapeutic strategies often focus on maintaining optimal salivary phosphate concentrations to prevent dental caries and manage the oral manifestations of systemic metabolic disorders.

Other names
OrthophosphatePhosphateSalivary phosphatePO4 3-Pi
02

Mechanism of action

Phosphate binders work by binding to inorganic phosphate in the gastrointestinal tract to form insoluble complexes, thereby preventing its absorption into the bloodstream (PubChem, 2024). In the oral cavity, fluoride ions facilitate the precipitation of calcium and phosphate ions onto the tooth surface, promoting the formation of fluorapatite, which is more resistant to acid dissolution than hydroxyapatite (Bardow et al., 2000).

03

Biological functions

Salivary pH bufferingTooth enamel remineralizationMineral homeostasisHydroxyapatite synthesis
04

Disease associations

Dental cariesChronic kidney disease (CKD)HyperphosphatemiaHypophosphatasia
05

Safety considerations

HypophosphatemiaGastrointestinal side effects (constipation, nausea)Vascular and soft tissue calcificationAluminum toxicity (with older binders)
06

Interacting drugs

Sevelamer

4 more in the full profile.

07

Biomarkers

Salivary phosphate concentrationSerum phosphate levelsFractional excretion of phosphate

Beyond the preview

Go deeper on Inorganic phosphate ion (Pi) (Pi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inorganic phosphate ion (Pi) (Pi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call